Senators Grassley, Blumenthal and Klobuchar demand Mylan reduce the price of its dominant treatment for life-threatening allergies.
Shares of the agrochemical giant got a boost Tuesday, following news Bayer AG may be courting the company with a sweeter deal.
Stocks hold onto gains through the morning session as new home sales hit a nearly eight-year high in July.
The FDA approved Merck's Keytruda, a drug to treat metastatic and recurrent cancer.
A potential blockbuster drug deal is reportedly in the works.
A recent note from RBC Capital on Gilead gained a lot of attention as well as a pickup in call-option purchases.
Shareholders of the struggling Canadian drugmaker got a major boost in Morgan Stanley's latest analyst note.
In the seesaw life of the struggling drugmaker, Morgan Stanley's bullishness is sending the stock higher.